Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)

Vietnam flag Vietnam · Delayed Price · Currency is VND
154,000
+8,800 (6.06%)
At close: Feb 27, 2026
33.91%
Market Cap 1.44T
Revenue (ttm) 546.57B
Net Income (ttm) 82.30B
Shares Out 9.33M
EPS (ttm) 8,819.10
PE Ratio 17.46
Forward PE n/a
Dividend 2,400.00 (1.56%)
Ex-Dividend Date Nov 21, 2025
Volume 936
Average Volume 75,015
Open 145,200
Previous Close 145,200
Day's Range 145,200 - 156,000
52-Week Range 100,200 - 189,000
Beta -0.38
RSI 57.38
Earnings Date Apr 17, 2026

About HNX:PMC

Pharmedic Pharmaceutical Medicinal Joint Stock Company engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam. The company offers non-prescription drug products for gastrointestinal and hepatobiliary; cardiovascular; respiratory; central nervous; skeletal; hormones; anti-infectives; urinary; endocrine and metabolic; vitamins and minerals; eye; ear – mouth/ throat; dermatologicals; allergy and immune; cardiovascular; diabetes; and other systems. It also pro... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 535
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PMC
Full Company Profile

Financial Performance

In 2025, HNX:PMC's revenue was 546.57 billion, an increase of 9.71% compared to the previous year's 498.18 billion. Earnings were 82.30 billion, an increase of 40.70%.

Financial Statements

News

There is no news available yet.